|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Kuopio University Hospital |
|---|---|
| Information provided by: | Kuopio University Hospital |
| ClinicalTrials.gov Identifier: | NCT00442494 |
Purpose
Atrial fibrillation is the most common arrhythmia to occur after cardiac surgery. Inflammatory response may be one etiological factor.
We hypothesized that intravenous corticosteroid administration after cardiac surgery prevents AF after cardiac surgery.
| Condition | Intervention | Phase |
|---|---|---|
|
Atrial Fibrillation |
Drug: intravenous hydrocortisone |
Phase III |
| Study Type: | Interventional |
| Study Design: | Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Feasibility of Corticosteroid in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Prospective, Double-Blind Randomized Multicenter Trial |
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | KUH5204515 |
| Study First Received: | March 1, 2007 |
| Last Updated: | January 11, 2008 |
| ClinicalTrials.gov Identifier: | NCT00442494 History of Changes |
| Health Authority: | Finland: National Agency for Medicines |
|
Atrial fibrillation after cardiac surgery |
|
Anti-Inflammatory Agents Hydrocortisone Heart Diseases Cortisol succinate |
Hydrocortisone acetate Atrial Fibrillation Arrhythmias, Cardiac |
|
Anti-Inflammatory Agents Hydrocortisone Pathologic Processes Heart Diseases Cortisol succinate Therapeutic Uses |
Cardiovascular Diseases Hydrocortisone acetate Atrial Fibrillation Pharmacologic Actions Arrhythmias, Cardiac |